M R Posner

Summary

Affiliation: Mount Sinai School of Medicine
Country: USA

Publications

  1. ncbi Integrating systemic agents into multimodality treatment of locally advanced head and neck cancer
    M R Posner
    Mount Sinai School of Medicine, Mount Sinai Medical Center, Tisch Cancer Institute, New York, NY 10029 6574, USA
    Ann Oncol 21:vii246-51. 2010
  2. ncbi Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial
    M R Posner
    The Tisch Cancer Institute, Mount Sinai Medical Center, New York, NY, USA
    Ann Oncol 22:1071-7. 2011

Collaborators

Detail Information

Publications2

  1. ncbi Integrating systemic agents into multimodality treatment of locally advanced head and neck cancer
    M R Posner
    Mount Sinai School of Medicine, Mount Sinai Medical Center, Tisch Cancer Institute, New York, NY 10029 6574, USA
    Ann Oncol 21:vii246-51. 2010
    ....
  2. ncbi Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial
    M R Posner
    The Tisch Cancer Institute, Mount Sinai Medical Center, New York, NY, USA
    Ann Oncol 22:1071-7. 2011
    ..The association between human papillomavirus (HPV) and overall survival (OS) in oropharynx cancer (OPC) was retrospectively examined in TAX 324, a phase III trial of sequential therapy for locally advanced head and neck cancer...